-
Madlanga Commission Deadline Extended to 2027 Amid Calls for Structural Justice Reform
-
Pradeep Antony, Smeha Manimegalai portray secret spouses in Mr & Mrs Office
-
Zelenskyy arrives in Dublin for meetings on Ukraine and peace efforts
-
Woman barred from every Greggs outlet after series of offences
-
Jury hears social-media image helped identify teen in Scarlett Faulkner case
-
Ketchup packets link suspect to break-in at Eddie Rocket’s restaurant
-
American Airlines passenger falls ill and vomits on three travellers
-
China's Factory Inflation Accelerates While Consumer Demand Stays Weak
-
Spain's General Strike Links Housing Crisis to Lost Purchasing Power
-
Euro-Area Inflation Reaches 4% as Energy Prices Jump
-
US Adds 165,000 Jobs as Unemployment Falls to 4.1%
-
Bank of England Raises Interest Rate to 4% as Energy Risks Intensify
-
Energy Costs Push OECD Inflation Up to 4.5%
-
OPEC Says Oil Output Is Near Prewar Levels Despite Shipping Disruptions
-
China's Trade Surplus Passes $1 Trillion as Technology Exports Surge
-
China's Singles' Day Exposes Persistent Consumer Caution
-
US Inflation Broadens as Fed Officials Consider Faster Rate Hikes
-
Irish police prepare for further hoax bomb threats after hundreds of schools targeted
-
RBA Inflation Target Origins: Why Australia Chose a Range Over Zero
-
Korea, Singapore and New Zealand Advance Green Trade Pact Talks
-
Ireland and Ukraine consider drone cooperation memorandum after Dublin talks
-
Sister recounts fatal machete attack as Irish murder trial continues
-
Georgia refrigeration company sues EPA after five-year HFC reprieve
-
HoloCoder technology promises brighter smartphone images and 3D depth data
-
EU proposes broad consumer safeguards for apps, subscriptions and ticketing
-
Early Black Friday Walking Pad Deals: Urevo and WalkingPad Discounts
-
Nvidia faces scrutiny over alleged Chinese intelligence link to Jensen Huang
-
Radical Numerics develops offline AI tool to detect engineered pathogens
-
Chennai orders inquiry after dogs die at shelter; two veterinarians face action
-
Kiara Advani Reveals Sidharth Malhotra’s Reaction to Toxic Backlash
-
Startup turns Chennai’s history and culture into an interactive world
-
Four firms compete to design Chennai’s model mobility corridors
-
EON Resources Inc. Announces First Oil Sale from Horizontal San Andres Development Program
-
StimCell's eBalance(R) Technology Demonstrates Significant Enhancement of Mitochondrial Function in Neuronal Study
-
LASE Corp Reports Third Quarter 2026 Results
-
Caledonia Mining Corporation Plc: ABRIDGED AND UNAUDITED QUARTERLY RESULTS AND DETAILS OF MANAGEMENT CONFERENCE CALL for the third quarter and nine months ended September 30, 2026 (the "Quarter" or "Q3 2026" and "Nine Months" respectively)
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 12
-
Hemogenyx Pharmaceuticals PLC Announces First Patient Treated in Second Adult Dose Cohort
-
Ocean Harvesters and Omega Protein Condemn Attacks on Commissioners and Fishing Families After Menhaden Vote
-
Chennai venue launches month-long festival devoted to full-length theatre
-
Study Finds Climate Change Threatens Cacti More Than Previously Thought
-
New Bay of Bengal low may form November 13 as Tamil Nadu outlook remains unclear
-
एलेक्स बोडी और SCANDIC PAY: Mastercard और VISA कार्ड — भुगतान की नई पीढ़ी
-
ALEX BODI och SCANDIC PAY: Mastercard- och VISA-kort – en ny generation betalningar
-
АЛЕКС БОДИ и SCANDIC PAY: карти Mastercard и VISA — ново поколение разплащания
-
알렉스 보디와 SCANDIC PAY: Mastercard·VISA 카드를 통한 차세대 결제
-
أليكس بودي وSCANDIC PAY: بطاقات Mastercard وVISA — جيل جديد من المدفوعات
-
ALEX BODIとSCANDIC PAY:Mastercard・VISAカードによる新世代の決済
-
ALEX BODI 與 SCANDIC PAY:Mastercard 與 VISA 卡——新一代支付方式
-
ALEX BODI a SCANDIC PAY: karty Mastercard a VISA – nová generace plateb
Johnson & Johnson faces UK lawsuit over talc cancer claim
Thousands of UK claimants have filed legal action against US pharmaceutical and cosmetics giant Johnson & Johnson alleging people diagnosed with cancers were exposed to asbestos in its talcum powder, lawyers said Thursday.
The company has faced a series of similar lawsuits in North America, with the latest UK claim filed in the High Court in London.
The law firm representing around 3,000 complainants in Britain said the compensation claim "is estimated to be more than £1 billion" ($1.3 billion).
They allege that either they or a family member developed forms of ovarian cancer or mesothelioma from using J&J's Baby Powder.
"The claim, which covers the period from 1965 to 2023, details how Johnson & Johnson knew that their talc products contained carcinogenic fibres, including asbestos, for more than 50 years," KP Law said.
The company "chose to keep it on the market in the pursuit of profit," it added, claiming J&J only withdrew their mineral talc from Britain in 2023, three years after it was taken off North American shelves.
A Johnson & Johnson spokesperson referred enquiries to its former consumer health arm Kenvue, which it separated from in August 2023.
"As a part of that separation, Kenvue retained the responsibility and any purported liability for talc related litigation outside of the United States and Canada," the spokesperson said.
A Kenvue spokesperson said the safety of J&J's Baby Powder "is backed by years of testing by independent and leading laboratories, universities, and health authorities in the UK and around the world".
The spokesperson added "the high-quality cosmetic grade talc" used in the powder "was compliant with any required regulatory standards, did not contain asbestos, and does not cause cancer".
US courts in April rejected a J&J offer to pay approximately $8 billion over 25 years to settle around 90,000 civil complaints there related to ovarian issues, without admitting liability.
The World Health Organization's cancer agency classified talc as "probably carcinogenic" for humans in July last year.
A summary of studies published in 2020 covering 250,000 women in the United States did not find a statistical link between the use of talc on the genitals and the risk of ovarian cancer.
P.M.Smith--AMWN